🧴 RETATRUTIDE – 10 MG KIT (2 MG / VIAL × 5 VIALS) – ZPHC PHARMA

🧪 Product Type

Peptide / Triple Hormonal Receptor Agonist

Active Ingredient: Retatrutide

Dosage Form: Lyophilized powder for reconstitution

Total Kit Strength: 10 MG

Per Vial Strength: 2 MG

Packaging: 5 vials per kit

📄 Description

RETATRUTIDE 10 MG KIT by ZPHC PHARMA is a cutting-edge investigational peptide designed to activate three key hormonal receptors:

• GLP-1 (Glucagon-Like Peptide-1)
• GIP (Gastric Inhibitory Polypeptide)
• Glucagon Receptor

This triple-agonist peptide has demonstrated promising effects in early research studies for its ability to support weight management, enhance insulin sensitivity, and improve metabolic performance. It is intended strictly for laboratory research and non-human use.

🔹 Product Features

• Concentration: 2 MG Retatrutide per vial
• Total Content: 10 MG per kit (5 vials × 2 MG)
• Form: Lyophilized peptide (requires reconstitution with bacteriostatic water)
• Storage: Keep refrigerated at 2°C–8°C after reconstitution
• Purity: High-purity pharmaceutical-grade research peptide

✅ Key Research Benefits

• 🧬 Multi-Receptor Activation
  Simultaneously targets GLP-1, GIP & glucagon receptors for synergistic metabolic impact
• 🔥 Weight Reduction Support
  Helps reduce food intake and increase fat oxidation
• 💉 Glucose & Insulin Modulation
  Promotes improved glycemic control and insulin function
• ⚖️ Energy Balance
  May contribute to increased energy expenditure and metabolic flexibility

📈 Suggested Research Use (For Laboratory Purposes Only)

Retatrutide should be reconstituted with bacteriostatic water prior to subcutaneous administration.

Dosage protocols vary based on study design, species model, and target endpoints.

⚠️ Possible Side Effects (Observed in Research)

• Transient nausea
• GI discomfort
• Appetite suppression
• Injection site redness or swelling

All effects appear to be dose-dependent and should be monitored throughout the study.

🚫 Contraindications (For Research Planning)

Retatrutide is not recommended in research models with:

• A history of medullary thyroid carcinoma
• Multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Known hypersensitivity to peptide compounds

🛒 Purchase & Availability

• For Research Use Only – Not for Human Consumption
• Format: 10 MG KIT (5 vials × 2 MG)
• Manufacturer: ZPHC PHARMA
• Available through certified research suppliers
• Estimated Shipping: 5–12 business days, depending on region